Influence of Genetic Polymorphisms on the Effect of High- and Standard-Dose Clopidogrel After Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Influence of Genetic Polymorphisms on the Effect of High- and Standard-Dose Clopidogrel After Percutaneous Coronary Intervention

Published:2012-05 Issue:22 Volume:59 Page:1928-1937
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Price Matthew J.,Murray Sarah S.,Angiolillo Dominick J.,Lillie Elizabeth,Smith Erin N.,Tisch Rebecca L.,Schork Nicholas J.,Teirstein Paul S.,Topol Eric J.

Funder

Bristol-Myers Squibb/sanofi-aventis

Accumetrics

Quest Diagnostics

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001

2. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial;Steinhubl;JAMA,2002

3. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study;Sabatine;JAMA,2005

4. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives;Angiolillo;J Am Coll Cardiol,2007

5. Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of Clopidogrel

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association;Circulation;2024-08-06

2. Cardiovascular pharmacogenomics – Molecular basis of protective and adverse drug response;Genomic and Molecular Cardiovascular Medicine;2024

3. Implementation of pharmacogenetic testing in medication reviews in a hospital setting;British Journal of Clinical Pharmacology;2023-06-22

4. Short‐term efficacy and safety of personalized antiplatelet therapy for patients with acute ischaemic stroke or transient ischaemic attack: A randomized clinical trial;British Journal of Clinical Pharmacology;2023-05-24

5. Pharmacogenetics of Antiplatelet Therapy;Annual Review of Pharmacology and Toxicology;2023-01-20